HIV and AIDS

This report is a case study of Cuba’s response to HIV. The report presents the background information on Cuba’s initial response to the HIV/AIDS epidemic, the establishment of AIDS sanatoria from 1986-1993 for taking care of HIV positive persons, the institution of an ambulatory care system for HIV treatment of people who want to remain at home, and introduction of antiretroviral (ART) treatment in 1996. Cuba began producing its own antiretrovirals in 2001, and 100% ART treatment was achieved in 2003. The report lists the drugs and regimens used in Cuba and the criteria to initiate ART.

This pamphlet discusses the risk of exposure to HIV during emergency situations such as war, civil strife, disasters or epidemics, since many of the conditions that facilitate the spread of HIV are present in emergencies.

This information sheet presents the federal budget request for domestic and global HIV/AIDS funding for fiscal year (FY) 2005. The budget request shows a $1.3 billion increase over 2004. The sheet explains the general funding categories and factors driving the budget increase. The fund categories are care, cash and housing assistance, prevention, research, and global. A chart of Federal funding for HIV/AIDS from FY 2003-2005 is provided.

This information sheet describes HHS/CDC's Global AIDS Program (GAP). Under he direction of the U.S. Global AIDS Coordinator’s Office, the CDC Global AIDS Program (GAP) is a partner in the unified U.S. Government (USG) effort to implement the President’s Emergency Plan for IDS Relief (the Emergency Plan).

This report describes the Drug Resources Enhancement Against AIDS and Malnutrition (DREAM) project in Mozambique. DREAM was created by the religious community of Sant’ Egidio in Rome. The main objective was to provide diagnosis and comprehensive treatment, prevention of perinatal transmission and of HIV transmission in the population through community care and home care services and mother and child prevention and care. The project uses a holistic approach by treating HIV with highly active antiretroviral therapy (HAART) as well as treating malnutrition, TB, malaria, and STDs.

This report presents guidelines for assessing quality, improvement, and accreditation in caring for persons with HIV. The report explains the rationale behind establishing guidelines, their uses, the purpose of accreditation, and the key principles of the accreditation framework. It lists the major categories of standards for HIV care, describes how the model standards were selected, and explains how to begin using the standards in an HIV care site or organization. The minimum set of standards to initiate antiretroviral therapy (ART) and proposed standards are provided.

This report focuses on the HIV/AIDS epidemic in the US and the work of the CDC’s division of HIV/AIDS prevention. It provides a brief history of the accomplishments since 1981, discusses the current status of the epidemic in the US and how CDC is responding, using surveillance data reported to CDC from the 25 states with long-standing HIV reporting. It looks back on the successes of HIV/AIDS prevention and presents future plans.

This monograph reports on key scientific, policy, social, ethical, and economic challenges and the ongoing research for a vaccine that would prevent HIV transmission.

This report discusses the association between stigma, discrimination, and human rights as they affect persons with HIV/AIDS. The report defines stigma and discrimination in different forms and contexts and presents case studies to illustrate twelve different approaches to reducing stigma.